CellaVision's image analysis becomes gold standard at labs in Swedish county council

CellaVision, which develops and sells digital morphology products for
the routine analysis of blood and other body fluids, has received a
first order from the Swedish county council Region Västra Götaland as
a part of the supply agreement from 2008. The order comprises two
units of the CellaVision® DM96 analyzer, which will be installed at
two of the region's university hospitals with clinical chemistry
laboratories. The aim is to tie the whole region together by using
software for remote access.

"We have been working with Sahlgrenska University Hospital since 2002
and we are very pleased that they are upgrading their current
analyzers. The fact that the entire region is introducing digital
morphology as a standard method of assessing cells in blood and body
fluids is an indication that the transition from manual to automated
microscopy is fully under way in the Nordic region," says Yvonne
Mårtensson, CEO of CellaVision.

CellaVision's products will connect the hospitals in the county
council, creating a more efficient flow of cell images and analytical
information in the health system. Digital morphology is an important
part of establishing a diagnosis for a number of diseases, including
certain infections as well as diseases of the blood.

"Introducing digital morphology in all our large clinical chemistry
laboratories is part of the region's strive for digitalized
laboratory medicine," says Stefan Jacobsson, Associate Professor at
the Clinical Chemistry laboratory at the Sahlgrenska University
Hospital. "Our experience from the Sahlgrenska and Östra hospitals is
directing us towards using digital morphology in several units. By
using CellaVision's technology we no longer have to rely on sample
results and images being transported by post or courier. Instead we
use our own network to transfer information, making response times
shorter and improving diagnostic quality. This technology also allows
us to digitally consult colleagues at other laboratories in the
region, which is more efficient."

The Region Västra Götaland and CellaVision entered into the agreement
in 2008, aiming at four analyzers with both blood and body fluid
applications. The first two will now be installed at the Sahlgrenska
and Östra University Hospitals in Gothenburg, and the other two will
be installed at two county hospitals. The agreement includes software
for networks and remote access, CellaVision® Remote Review Software,
which will allow the university hospital in Mölndal and four other
hospitals to assess cell images remotely. In total, nine hospitals in
the county will be equipped with the education software CellaVision®
Competency Software.


For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82. E-mail: yvonne.martensson@cellavision.com


About Region Västra Götaland
For information about healthcare in the region, visit
www.vgregion.se/sjukvard.


About CellaVision
CellaVision AB develops, markets, and sells market leading image
analysis based systems for routine analysis of blood and other body
fluids. The company has a core competence in development of software
and hardware for automatic image analysis of cells and cell changes
for applications in health and medical care. The company develops and
markets systems for automatic differentials of white blood cells and
red morphology, and software for education and quality assurance of
differentials. The company's associates have expertise in advanced
imaging analysis, artificial intelligence, and automated microscopy.

The company headquarters are in Lund, Sweden. The company also has
subsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan.
For more information, visit www.cellavision.com.

CellaVision's share is listed on First North Premier at the OMX
Stockholm Stock Exchange. The company's Certified Advisor is Remium
AB.